The prediction potential of neutrophil-to-lymphocyte ratio for the therapeutic outcomes of programmed death receptor-1/programmed death ligand 1 inhibitors in non-small cell lung cancer patients-Reference-Cited by-同舟云学术

The prediction potential of neutrophil-to-lymphocyte ratio for the therapeutic outcomes of programmed death receptor-1/programmed death ligand 1 inhibitors in non-small cell lung cancer patients

Published:2020-08-21 Issue:34 Volume:99 Page:e21718
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Huang Ying,Shen Aizong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference57 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer;Kelly;Ann Oncol,2019

3. Real-world treatment patterns, overall survival, and occurrence and costs of adverse events associated with first-line therapies for medicare patients 65 years and older with advanced non–small-cell lung cancer: a retrospective study;Bittoni;Clin Lung Cancer,2018

4. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation;Mu;Med Oncol,2011

5. Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancer;Qin;Cancer Med,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of pretreatment neutrophil-to-lymphocyte ratio with clinical outcomes in cancer immunotherapy: An evidence synthesis from 30 meta-analyses;International Immunopharmacology;2024-05

3. Modified-Dose Pembrolizumab and Prognostic Outcomes among Non-Small Cell Lung Cancer Patients: A Chart Review Study;International Journal of Environmental Research and Public Health;2022-05-15

4. Prognostic Value of Pretreatment Geriatric Nutrition Risk Index in Lung Cancer Patients: A Meta-Analysis;Nutrition and Cancer;2022-04-04

5. The Prediction Potential of the Pretreatment Lung Immune Prognostic Index for the Therapeutic Outcomes of Immune Checkpoint Inhibitors in Patients With Solid Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-09-23